# OnCo record nct07455903 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07455903/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07455903", "NCT07455903" ;
  schema:name "Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT"@en ;
  schema:description "A phase 2 trial of Leuprolide, Degarelix, Relugolix, Triptorelin, Bicalutamide and Flotufolastat F-18 in Prostate cancer, run by Baptist Health South Florida, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07455903/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07455903> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:drugs <https://onco.cc/drugs/leuprolide/>, <https://onco.cc/drugs/degarelix/>, <https://onco.cc/drugs/relugolix/>, <https://onco.cc/drugs/triptorelin/>, <https://onco.cc/drugs/bicalutamide/>, <https://onco.cc/drugs/flotufolastat/> .